breast cancer
ASCO Meeting: Enhertu + Perjeta Potential First-Line Combo for Metastatic Breast Cancer
Trastuzumab deruxtecan combined with Perjeta may become first-line therapy for people with metastatic HER2-positive ...
JUNE 16, 2025
First and Only Ready-to-Dilute, Multi-Dose Vial of Thiotepa Approved
Shorla Oncology, a U.S.-Ireland specialty pharmaceutical company, announced that the FDA has granted approval for ...
MAY 8, 2025
New Treatments Emerge for Early-Stage HR+ Breast Cancer
New treatments for early-stage hormone receptor–positive breast cancer are emerging, with some of the ...
MARCH 31, 2025
Cryoablation On Par With Excision for Early-Stage Breast Cancer Recurrence
Five-year follow-up data from an investigation of cryoablation with early-stage, low-risk breast cancer show that ...
MARCH 1, 2025
Is Breast Cancer Metastasis a Hereditary Disorder?
Scientists have been on a quest to identify which malignant mutations within the tumor allow rogue cells to break ...
FEBRUARY 7, 2025
Rise in Breast Cancer Among Young Women Requires New Models of Care
Supportive care programs can empower young women to face the unique challenges of a breast cancer diagnosis.
JANUARY 31, 2025
Environmental Exposure a Risk Factor for Breast Cancer
Environmental inequities are a significant contributor to breast cancer disparities among Black women, highlighting ...
JANUARY 24, 2025
FDA Approves Datroway for Unresectable or Metastatic, HR-positive, HER2-negative Breast Cancer
The FDA has approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo), a Trop-2−directed antibody and ...
JANUARY 22, 2025
Fluorescence May Usher In New Era in Oncoplastic Surgery
Surgical treatment of breast cancer has come a long way since Halsted’s radical mastectomy.
DECEMBER 27, 2024
The Case for Population-Based Genetic Testing in Breast Cancer
When genetic testing guidelines were established in the 1990s, genetic tests were expensive and came with concerns ...
DECEMBER 23, 2024
Debate: Annual MRI for Women With BRCA Mutation?
The National Comprehensive Cancer Network (NCCN) recommends annual breast MRI for women who have or are likely to ...
DECEMBER 4, 2024
Expert Taps Best Papers In Breast Cancer From Last Year
Helen Pass, MD, presented her choices for the best breast cancer–related papers of 2023 at the American ...
NOVEMBER 13, 2024
